1. Home
  2. UFG vs NRSN Comparison

UFG vs NRSN Comparison

Compare UFG & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Uni-Fuels Holdings Limited

UFG

Uni-Fuels Holdings Limited

HOLD

Current Price

$0.99

Market Cap

33.1M

Sector

Energy

ML Signal

HOLD

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$0.84

Market Cap

26.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UFG
NRSN
Founded
2021
2017
Country
Singapore
Israel
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.1M
26.4M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
UFG
NRSN
Price
$0.99
$0.84
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$14.00
AVG Volume (30 Days)
273.6K
495.3K
Earning Date
10-28-2025
04-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$195,620,824.00
N/A
Revenue This Year
$41.40
N/A
Revenue Next Year
$25.00
N/A
P/E Ratio
$172.99
N/A
Revenue Growth
49.71
N/A
52 Week Low
$0.66
$0.81
52 Week High
$11.00
$2.60

Technical Indicators

Market Signals
Indicator
UFG
NRSN
Relative Strength Index (RSI) 47.26 34.72
Support Level $0.75 $0.86
Resistance Level $1.15 $1.24
Average True Range (ATR) 0.10 0.10
MACD 0.07 -0.03
Stochastic Oscillator 66.57 1.01

Price Performance

Historical Comparison
UFG
NRSN

About UFG Uni-Fuels Holdings Limited

Uni-Fuels Holdings Ltd is a service provider of marine fuels solutions. The company market, resell and brokers marine fuels products such as VLSFO, HSFO, and MGO. It offers these products to shipping companies and marine fuels suppliers in-port and offshore. In addition, the company may from time to time provide shipping-related services to its customers including but not limited to the arrangement of ship agents, ship provisions and marine fuels surveyors. It operates an integrated business model where It serves its customers through two operating models, sales of marine fuels solutions and brokerage.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: